Side-by-side comparison of AI visibility scores, market position, and capabilities
Cincinnati OH jet engine technology (NYSE: GE) at $38.7B 2024 revenue; 44,000+ commercial engines in service, LEAP powers 737 MAX/A320neo via CFM JV, 26.2% operating margins competing with Pratt & Whitney and Rolls-Royce.
GE Aerospace is a Cincinnati, Ohio-based jet engine and aviation propulsion technology company — publicly traded on the New York Stock Exchange (NYSE: GE) as an S&P 500 Industrials component — designing, manufacturing, and servicing commercial and military aircraft engines through approximately 52,000 employees serving commercial airlines, defense agencies, and regional operators in 170+ countries. GE Aerospace became a standalone publicly traded company in April 2024 when General Electric completed its multi-year strategic separation — spinning off GE Vernova (energy transition) separately and retaining the aerospace and defense engine business as the pure-play GE Aerospace entity. In full year 2024 (its first year as a standalone company), GE Aerospace reported revenue of $38.7 billion, operating profit growth of 25%, and operating margin expansion to 26.2% — with Q4 2024 orders up 46%, Q4 revenue of $10.8 billion (+14%), and free cash flow growth exceeding 20%. CEO Larry Culp has led GE Aerospace through the conglomerate separation, maintaining LEAP engine production ramp for the Boeing 737 MAX and Airbus A320neo in partnership with CFM International (GE's 50/50 joint venture with Safran). GE Aerospace's total installed commercial engine base exceeds 44,000 engines, with a services backlog exceeding $150 billion — creating decades of recurring maintenance, repair, and overhaul (MRO) revenue.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.